[Pediatric guiding principles. 32. Therapy of the most common helminthiases].
D000724:Ancylostomiasis / Q000188:drug therapy; D000871:Anthelmintics / Q000008:administration & dosage* / Q000009:adverse effects; D001196:Ascariasis / Q000188:drug therapy; D001598:Bephenium Compounds / Q000008:administration & dosage; D002590:Cestode Infections / Q000188:drug therapy; D002648:Child; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy; D010123:Oxyuriasis / Q000188:drug therapy; D010879:Piperazines / Q000008:administration & dosage; D011774:Pyrvinium Compounds / Q000008:administration & dosage; D013322:Strongyloidiasis / Q000188:drug therapy; D013622:Taeniasis / Q000188:drug therapy; D014257:Trichuriasis / Q000188:drug therapy
D000871:Anthelmintics; D001598:Bephenium Compounds; D010879:Piperazines; D011774:Pyrvinium Compounds
Pädiatrische Arbeitsrichtlinien. 32. Therapie der wichtigsten Helminthosen.